These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 15630040)

  • 41. [Cardiometabolic high risk patients with abdominal obesity. Frequency and risk factor profile in primary care].
    Scholze J; Lilienthal W; Bramlage P
    MMW Fortschr Med; 2007 Sep; 149 Suppl 3():103-10. PubMed ID: 17955787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Free fatty acid receptor family: novel targets for the treatment of diabetes and dyslipidemia.
    Bernard J
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1078-83. PubMed ID: 18821469
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antihypertensive therapy: risk stratification in diabetes and cardiac diseases].
    Baumgart P
    MMW Fortschr Med; 2006 Mar; 148(11):57, 59-60. PubMed ID: 16612965
    [No Abstract]   [Full Text] [Related]  

  • 44. [CME: Antidiabetics in renal failure and kidney transplantation].
    Seer C; Lehmann R
    Praxis (Bern 1994); 2016 Jan; 105(2):69-74; quiz 75-6. PubMed ID: 26787327
    [No Abstract]   [Full Text] [Related]  

  • 45. Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
    Rabelink TJ
    Nephrol Dial Transplant; 2004 Jan; 19(1):23-6. PubMed ID: 14671033
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of hypertension and diabetes mellitus in patients with chronic kidney disease: a review.
    Rasu RS; Crawford T; Manley HJ; Balkrishnan R
    Expert Opin Pharmacother; 2007 Oct; 8(15):2543-51. PubMed ID: 17931089
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adverse interactions of drugs.
    Med Lett Drugs Ther; 1977 Jan; 19(2):5-12. PubMed ID: 834163
    [No Abstract]   [Full Text] [Related]  

  • 49. Current Opinion in Cardiology. Current world literature.
    Curr Opin Cardiol; 2009 Jul; 24(4):380-93. PubMed ID: 19509487
    [No Abstract]   [Full Text] [Related]  

  • 50. Recommendations for the use of everolimus (Certican) in heart transplantation: results from the second German-Austrian Certican Consensus Conference.
    Rothenburger M; Zuckermann A; Bara C; Hummel M; Strüber M; Hirt S; Lehmkuhl H;
    J Heart Lung Transplant; 2007 Apr; 26(4):305-11. PubMed ID: 17403469
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Isolated perverted head-shaking nystagmus in focal cerebellar infarction.
    Kim JS; Ahn KW; Moon SY; Choi KD; Park SH; Koo JW
    Neurology; 2005 Feb; 64(3):575-6. PubMed ID: 15699406
    [No Abstract]   [Full Text] [Related]  

  • 52. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevention of cardiovascular events in diabetes.
    Sigal R; Malcolm J; Meggison H
    Clin Evid; 2004 Jun; (11):777-806. PubMed ID: 15652037
    [No Abstract]   [Full Text] [Related]  

  • 54. Treatment of diabetes mellitus: beyond glycaemic control.
    Unnikrishnan R; Mohan V
    Natl Med J India; 2007; 20(6):304-6. PubMed ID: 18335799
    [No Abstract]   [Full Text] [Related]  

  • 55. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 56. [Gout and diabetes. I. Gout and its relation to diabetes].
    Bernheim C; Ott H; Zahnd G; Martin E
    Schweiz Med Wochenschr; 1968 Jan; 98(2):33-41. PubMed ID: 5670485
    [No Abstract]   [Full Text] [Related]  

  • 57. Hypertension: a review and rationale of treatment.
    Copley JB; Rosario R
    Dis Mon; 2005; 51(10-11):548-614. PubMed ID: 16360376
    [No Abstract]   [Full Text] [Related]  

  • 58. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 59. Underuse of cardioprotective treatment by the elderly with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Metab; 2008 Apr; 34(2):169-76. PubMed ID: 18396087
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of simultaneous pancreas and kidney transplantation on cardiovascular risk factors in patients with type 1 diabetes mellitus.
    Luan FL; Miles CD; Cibrik DM; Ojo AO
    Transplantation; 2007 Aug; 84(4):541-4. PubMed ID: 17713440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.